keynote-966: pembrolizumab, gemcitabine and cisplatin for cca
Published 4 years ago • 901 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
1:14
hrqol in keynote-966: pembrolizumab with gemcitabine and cisplatin for advanced biliary tract cancer
-
0:33
keynote-966: pembrolizumab gem/cis vs gemc/cis alone in advanced biliary tract cancer
-
2:04
hepatitis b outcomes in keynote-966: hbv pts on pembrolizumab gem/cis for advanced btc
-
4:09
keynote-966: three-year follow-up for advanced biliary tract cancer
-
1:04
overcoming resistance to icis in biliary tract cancers
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
2:06
checkmate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinoma
-
3:57
pembrolizumab plus 5-fu and cisplatin for first-line treatment in...
-
2:34
gemcitabine, cisplatin, and nab-paclitaxel in advanced biliary tract cancers
-
2:15
the role of immunotherapy in cholangiocarcinoma
-
3:47
adjuvant pembrolizumab, durvalumab, and more considerations from uc trials presented at esmo 2024
-
1:59
swog 1815: gemcitabine, cisplatin, and nab-paclitaxel in biliary tract cancer
-
2:36
pembrolizumab benefit confirmed for cisplatin-ineligible advanced uc patients | peter o’donnell
-
2:25
keynote-224: second-line pembrolizumab for advanced hepatocellular carcinoma
-
6:37
nivolumab gemcitabine-cisplatin vs. gemcitabine-cisplatin in metastatic urothelial cancer | crsf
-
2:07
nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced muc
-
2:01
dr. picozzi on prognostic value of pathologic response to chemo in pancreatic cancer
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
1:38
keynote 361: pembrolizumab compared to gemcarbo - bladder cancer video library